Brief: Biocryst Presents New Clinical Data And Real-World Evidence Demonstrating Impact Of Hae Portfolio At The 2026 European Academy Of Allergy And Clinical Immunology Annual Meeting
12/06/2026 12:03
BRIEF-Biocryst Presents New Clinical Data And Real-World Evidence Demonstrating Impact Of Hae Portfolio At The 2026 European Academy Of Allergy And Clinical Immunology Annual Meeting June 12 (Reuters) - BioCryst Pharmaceuticals Inc BCRX.O:
BIOCRYST PRESENTS NEW CLINICAL DATA AND REAL-WORLD EVIDENCE DEMONSTRATING IMPACT OF HAE PORTFOLIO AT THE 2026 EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY ANNUAL MEETING
Source text: ID:nGNX2RMPRr
Further company coverage: BCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioCryst Pharmaceuticals
See all newsBrief: Biocryst Presents New Clinical Data And Real-World Evidence Demonstrating Impact Of Hae Portfolio At The 2026 European Academy Of Allergy And Clinical Immunology Annual Meeting
U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber
BioCryst falls on surprise quarterly loss